| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |